Literature DB >> 9407409

Periodontal management of gingival overgrowth in the heart transplant patient: a case report.

A Khocht1, L C Schneider.   

Abstract

Heart transplant patients take several medications that could affect their periodontal health. Gingival overgrowth associated with cyclosporin (immunosuppressant agent) and nifedipine (calcium channel blocker) is well documented. Candidal infections often develop because of immune suppression. This report describes the clinical and histopathological changes in the gingival tissues of a heart transplant patient and their management. The gingival tissues exhibited pronounced enlargement. The gingivae were lobulated, and the surface of the lobulations was pebbly and granular. Biopsies showed lobules of fibrous connective tissue covered by stratified squamous epithelium. The outer surfaces were dotted with numerous smaller papillations. Candidal hyphae were present in the superficial layers of the epithelium. The extensive papillary lesions appear to be related to candidiasis and constitute a condition which is best designated as papillary stomatitis. Hyperplastic gingival tissues were excised, and the patient was placed on periodic maintenance. One-year postoperative follow-up showed minor gingival growth.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9407409     DOI: 10.1902/jop.1997.68.11.1140

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  10 in total

Review 1.  Drugs, medications and periodontal disease.

Authors:  P A Heasman; F J Hughes
Journal:  Br Dent J       Date:  2014-10       Impact factor: 1.626

2.  The Oral Cavity State in Renal Transplant Recipients.

Authors:  Marija Gašpar; Ana Glavina; Kristina Grubišić; Ivan Sabol; Mirela Bušić; Marinka Mravak
Journal:  Acta Stomatol Croat       Date:  2015-09

3.  Treatment of drug-induced gingival overgrowth by full-mouth disinfection: A non-surgical approach.

Authors:  Aena Jain Pundir; Siddharth Pundir; R K Yeltiwar; Sana Farista; V Gopinath; T S Srinivas
Journal:  J Indian Soc Periodontol       Date:  2014-05

4.  Presence of Candida spp. in the oral cavity of heart transplantation patients.

Authors:  Patrícia Monteiro Ribeiro; Fernando Bacal; Cristiane Yumi Koga-Ito; Juliana Campos Junqueira; Antonio Olavo Cardoso Jorge
Journal:  J Appl Oral Sci       Date:  2011 Jan-Feb       Impact factor: 2.698

5.  Calcium channel blocker induced gingival overgrowth.

Authors:  L Michael Prisant; Wayne Herman
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Jul-Aug       Impact factor: 3.738

6.  Laser-Assisted Periodontal Management of Drug-Induced Gingival Overgrowth under General Anesthesia: A Viable Option.

Authors:  Tupili Muralikrishna; Butchibabu Kalakonda; Sumanth Gunupati; Pradeep Koppolu
Journal:  Case Rep Dent       Date:  2013-05-29

7.  Efficacy of AZM therapy in patients with gingival overgrowth induced by Cyclosporine A: a systematic review.

Authors:  Marco Clementini; Gianluca Vittorini; Alessandro Crea; Maria Rosaria Gualano; Ludovica Antonella Macrì; Giorgio Deli; Giuseppe La Torre
Journal:  BMC Oral Health       Date:  2008-12-16       Impact factor: 2.757

8.  Using Salivary Nitrite and Nitrate Levels as a Biomarker for Drug-Induced Gingival Overgrowth.

Authors:  Erkan Sukuroglu; Güliz N Güncü; Kamer Kilinc; Feriha Caglayan
Journal:  Front Cell Infect Microbiol       Date:  2015-12-01       Impact factor: 5.293

Review 9.  Drug-induced gingival overgrowth: A critical insight into case reports from over two decades.

Authors:  Pramod Samudrala; Vijay Kumar Chava; Tanguturi Sri Chandana; Rachakonda Suresh
Journal:  J Indian Soc Periodontol       Date:  2016 Sep-Oct

10.  miR-4651 inhibits cell proliferation of gingival mesenchymal stem cells by inhibiting HMGA2 under nifedipine treatment.

Authors:  Xiao Han; Ruzhuang Yang; Haoqing Yang; Yangyang Cao; Nannan Han; Chen Zhang; Ruitang Shi; Zhengting Zhang; Zhipeng Fan
Journal:  Int J Oral Sci       Date:  2020-03-31       Impact factor: 6.344

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.